Product image of Nutryelt (Chromic Chloride, Copper Gluconate, Ferrous Gluconate, Manganese Gluconate, Potassium Iodide, Sodium) supplied by GNH India

Nutryelt

Active Ingredient:
Chromic Chloride, Copper Gluconate, Ferrous Gluconate, Manganese Gluconate, Potassium Iodide, Sodium
Origin:
EU

Nutryelt (Chromic Chloride, Copper Gluconate, Ferrous Gluconate, Manganese Gluconate, Potassium Iodide, Sodium)

Chromic Chloride, Copper Gluconate, Ferrous Gluconate, Manganese Gluconate, Potassium Iodide and Sodium, the active ingredients in Nutryelt, are trace element salts presented as an intravenous solution for parenteral nutrition support. They provide essential minerals that help maintain enzymatic activity and metabolic balance in patients receiving total parenteral nutrition.

GNH India supplies Nutryelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product meets EU quality standards and is manufactured under GMP conditions.

Manufacturer / TM Owner

Laboratoire Aguettant

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nutryelt is a parenteral trace element supplement used to address micronutrient deficiencies in patients receiving intravenous nutrition.

  • Micronutrient deficiency in total parenteral nutrition (TPN): helps maintain adequate levels of essential trace elements.
  • Critical illness requiring parenteral support: supports enzymatic functions and metabolic processes.
  • Post‑operative patients on IV feeding: prevents deficiency‑related complications.
  • Burn patients on prolonged IV feeding: reduces risk of trace element depletion.

How It Works

  • After intravenous administration, the salts dissociate into their constituent ions—chromium, copper, iron, manganese, iodine, and sodium. These ions act as cofactors for a variety of enzymatic reactions, participate in oxidative‑reduction processes, support thyroid hormone synthesis, and contribute to cellular antioxidant defenses, thereby correcting trace‑element deficits associated with parenteral nutrition.

Side Effects

Nutryelt may be associated with adverse reactions following intravenous infusion.

Common Side Effects

  • Injection site pain or erythema.
  • Transient mild electrolyte imbalance (e.g., mild hypernatremia).
  • Mild headache or dizziness.

Serious or Rare Side Effects

  • Anaphylactic or severe hypersensitivity reaction.
  • Significant electrolyte disturbances such as hyperkalemia or severe hypernatremia.
  • Iron overload leading to hepatic or renal toxicity.
  • Methemoglobinemia from excess ferrous ion exposure.

Precautions & Warnings

Use Nutryelt with careful clinical monitoring to minimize risks.

  • Baseline assessment: evaluate patient’s trace element status before initiation.
  • Electrolyte monitoring: check serum levels of chromium, copper, iron, manganese, iodine, and sodium regularly.
  • Hypersensitivity: avoid in patients with known allergy to any component.
  • Renal impairment: use cautiously and adjust monitoring frequency.
  • Fluid balance: consider total sodium load in patients at risk of fluid overload.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Nutryelt can interact with other medications and solutions that affect electrolyte balance.

Major Interactions (Avoid)

  • Concurrent high‑dose iron preparations: risk of iron overload.
  • Potassium‑sparing diuretics: may precipitate hyperkalemia.
  • Sodium‑rich IV fluids: increase risk of fluid overload.

Moderate Interactions (Monitor Closely)

  • Anticoagulants: trace elements may influence coagulation parameters.
  • Thyroid hormone therapy: iodine content can affect thyroid function tests.
  • Chelating agents (e.g., deferoxamine): may reduce the efficacy of the trace elements.

Frequently Asked Questions

Nutryelt is an intravenous trace‑element solution used to supply essential minerals such as chromium, copper, iron, manganese, iodine and sodium to patients receiving total parenteral nutrition or other forms of prolonged intravenous feeding.

The active ingredients dissociate into individual ions after infusion. These ions serve as cofactors for metabolic enzymes, support antioxidant defenses, aid thyroid hormone synthesis, and help maintain normal cellular function, thereby correcting trace‑element deficiencies.

The dose of Nutryelt is determined by the prescribing clinician based on the patient’s individual trace‑element requirements, laboratory values, and overall clinical condition. No fixed regimen is provided here.

Safety of Nutryelt in pregnancy or lactation has not been fully established. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Nutryelt provides a comprehensive blend of six essential trace elements in a single IV formulation, which can simplify inventory and reduce the need for multiple separate infusions. Alternative products may contain a subset of these elements or differ in concentration, stability, or storage requirements.

Nutryelt must be stored at 2‑8 °C, protected from light, and should not be frozen or shaken. Use aseptic technique during preparation and administer promptly after removal from refrigeration.

Nutryelt is administered intravenously, typically added to a compatible carrier solution or infused directly according to the prescribing clinician’s instructions. Administration should follow aseptic standards and be monitored for any infusion‑related reactions.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, significant electrolyte disturbances (e.g., hyperkalemia, hypernatremia), iron overload leading to hepatic or renal toxicity, and rare cases of methemoglobinemia. Prompt recognition and management are essential.

Nutryelt should be avoided in patients with known hypersensitivity to any of its components, in those with uncontrolled electrolyte imbalances, severe renal or hepatic failure where accumulation could occur, and in individuals where the risk of fluid overload outweighs the benefit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chromic Chloride, Copper Gluconate, Ferrous Gluconate, Manganese Gluconate, Potassium Iodide, Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT